OCS

$0.00

(

0.00%

)
Quote details

stock

Oculis Holding AG Ordinary shares

NASDAQ | OCS

19.15

USD

$0.00

(

0.00%

)

At Close (As of Nov 17, 2025)

$1.13B

Market Cap

-

P/E Ratio

-2.72

EPS

$23.08

52 Week High

$14.00

52 Week Low

HEALTHCARE

Sector

OCS Chart

Recent Chart
Price Action

OCS Technicals

Tags:

OCS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (CHF)
Gross Profit -$51M
Total Revenue $686K
Cost Of Revenue $52M
Costof Goods And Services Sold $52M
Operating Income -$73M
Selling General And Administrative $22M
Research And Development $52M
Operating Expenses $22M
Investment Income Net -
Net Interest Income $1.5M
Interest Income $2.2M
Interest Expense $639K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $406K
Income Before Tax -$86M
Income Tax Expense -$160K
Interest And Debt Expense -
Net Income From Continuing Operations -$86M
Comprehensive Income Net Of Tax -
Ebit -$73M
Ebitda -$73M
Net Income -$86M

Revenue & Profitability

Earnings Performance

OCS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (CHF)
Total Assets $120M
Total Current Assets $105M
Cash And Cash Equivalents At Carrying Value $28M
Cash And Short Term Investments $28M
Inventory -
Current Net Receivables $777K
Total Non Current Assets $15M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $13M
Intangible Assets Excluding Goodwill $13M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $71M
Other Current Assets $5.5M
Other Non Current Assets -
Total Liabilities $47M
Total Current Liabilities $44M
Current Accounts Payable $5.9M
Deferred Revenue -
Current Debt -
Short Term Debt $315K
Total Non Current Liabilities $2.7M
Capital Lease Obligations $1.2M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.2M
Other Current Liabilities $38M
Other Non Current Liabilities -
Total Shareholder Equity $73M
Treasury Stock -
Retained Earnings -$286M
Common Stock $446K
Common Stock Shares Outstanding $40M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (CHF)
Operating Cashflow -$47M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $406K
Capital Expenditures $230K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$18M
Cashflow From Financing $54M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$86M

yearly Income Statement (As of Dec 31, 2024)

Field Value (CHF)
Gross Profit -$51M
Total Revenue $686K
Cost Of Revenue $52M
Costof Goods And Services Sold $52M
Operating Income -$73M
Selling General And Administrative $22M
Research And Development $52M
Operating Expenses $22M
Investment Income Net -
Net Interest Income $1.5M
Interest Income $2.2M
Interest Expense $639K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $406K
Income Before Tax -$86M
Income Tax Expense -$160K
Interest And Debt Expense -
Net Income From Continuing Operations -$86M
Comprehensive Income Net Of Tax -
Ebit -$73M
Ebitda -$73M
Net Income -$86M

OCS News

OCS Profile

Oculis Holding AG Ordinary shares Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Oculis Holding AG is a pioneering biopharmaceutical company located in Zug, Switzerland, dedicated to transforming the treatment landscape for ophthalmic diseases through its innovative topical therapies. Utilizing cutting-edge formulation technologies, Oculis targets significant unmet medical needs in vision care, aiming to improve patient outcomes with convenient and effective therapies. With a strong pipeline of products addressing both acute and chronic eye conditions, the company is well-positioned to make a substantial impact in the ophthalmology sector, thus attracting the attention of institutional investors seeking opportunities in novel therapeutic solutions.

WTO
+19.50%
$0.02
LPTX
+368.57%
$2.05
VINE
+1.80%
$0.40
APLT
+30.18%
$0.28
AMIX
+59.55%
$1.16
KXIN
-9.26%
$0.27
EPWK
+16.62%
$0.04
VHAI
+33.33%
$0.00
ONDS
-12.88%
$6.25
NVDA
-2.77%
$184.89
CHR
-2.87%
$0.04
ASST
-6.95%
$1.00
TSLA
+1.14%
$408.98
GLMD
+4.80%
$1.09
PFE
0.00%
$25.05
DVLT
+4.09%
$1.90
QUBT
+8.63%
$11.51
AXDX
-61.36%
$0.03
GNS
-10.82%
$0.76
SOFI
-4.20%
$26.65
PLUG
-7.83%
$2.06
DNN
-4.03%
$2.38
ACHR
-5.78%
$7.42
CIFR
-3.81%
$14.36
F
-2.69%
$12.83
BYND
-5.09%
$1.02
DFLI
-8.26%
$0.74
BITF
+3.05%
$2.65
ADAP
-15.14%
$0.05
AMZN
-0.93%
$232.49
ETHD
+11.65%
$5.83
RIVN
-3.70%
$14.55
INTC
-2.81%
$34.51
AAPL
-0.19%
$272.41
BURU
-14.99%
$0.21
MKDW
-18.20%
$0.16
BMNR
-10.85%
$30.66
TLRY
-4.93%
$1.02
KVUE
-3.00%
$16.16
RIG
+0.24%
$4.02
NIO
-1.21%
$6.08
GOOGL
+3.20%
$285.26
AAL
-3.29%
$12.34
MARA
-6.71%
$11.18
GPUS
-12.37%
$0.24
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
SNAP
-5.89%
$8.06
ADD
-25.47%
$0.05
HPE
-7.74%
$21.06
PLTR
-3.12%
$168.56
MSPR
+13.64%
$0.51
ASBP
-10.91%
$0.09
RGTI
-3.56%
$24.57
SRM
+53.27%
$10.30
WULF
+0.29%
$11.02
PLTD
+2.57%
$7.01
XPEV
-10.23%
$22.44
GRAB
-1.81%
$5.31
BTG
-2.57%
$3.99
RXRX
-4.38%
$4.14
CAN
-5.35%
$0.84
HOOD
-7.13%
$113.76
GOOG
+3.15%
$285.73
AMD
-3.26%
$238.76
OWL
-5.77%
$13.77
HIMS
-3.78%
$35.58
WLGS
-5.57%
$0.04
MSFT
+1.36%
$510.18
MTSR
-0.35%
$70.50
AMC
-5.92%
$2.14
NOK
-0.31%
$6.70
IONZ
-1.30%
$5.13
IREN
-0.28%
$46.23
SMCI
-6.42%
$34.08
BTBT
-3.32%
$2.32
BBD
-1.76%
$3.61
WBD
-1.77%
$22.62
ABEV
-0.39%
$2.54
MU
-2.57%
$240.47
SOUN
-6.32%
$11.40
QBTS
-5.16%
$22.39
TWOH
0.00%
$0.00
BTE
-4.69%
$3.01
AFMD
-34.94%
$0.18
CLSK
-3.42%
$10.58
T
-0.29%
$25.51
QS
-3.42%
$12.97
CORZ
-1.51%
$14.93
BAC
-2.03%
$51.53
PLTZ
+5.52%
$7.26
IVVD
+20.14%
$2.82
APLD
-3.08%
$22.92
EOSE
-6.03%
$12.96
CRWV
-4.87%
$73.58
BULL
-4.21%
$8.63
CRCL
-6.78%
$76.33
CRCA
-13.69%
$4.16
CGC
-2.24%
$1.04
SMR
-7.19%
$20.83
WTO
+19.50%
$0.02
LPTX
+368.57%
$2.05
VINE
+1.80%
$0.40
APLT
+30.18%
$0.28
AMIX
+59.55%
$1.16
KXIN
-9.26%
$0.27
EPWK
+16.62%
$0.04
VHAI
+33.33%
$0.00
ONDS
-12.88%
$6.25
NVDA
-2.77%
$184.89
CHR
-2.87%
$0.04
ASST
-6.95%
$1.00
TSLA
+1.14%
$408.98
GLMD
+4.80%
$1.09
PFE
0.00%
$25.05
DVLT
+4.09%
$1.90
QUBT
+8.63%
$11.51
AXDX
-61.36%
$0.03
GNS
-10.82%
$0.76
SOFI
-4.20%
$26.65
PLUG
-7.83%
$2.06
DNN
-4.03%
$2.38
ACHR
-5.78%
$7.42
CIFR
-3.81%
$14.36
F
-2.69%
$12.83
BYND
-5.09%
$1.02
DFLI
-8.26%
$0.74
BITF
+3.05%
$2.65
ADAP
-15.14%
$0.05
AMZN
-0.93%
$232.49
ETHD
+11.65%
$5.83
RIVN
-3.70%
$14.55
INTC
-2.81%
$34.51
AAPL
-0.19%
$272.41
BURU
-14.99%
$0.21
MKDW
-18.20%
$0.16
BMNR
-10.85%
$30.66
TLRY
-4.93%
$1.02
KVUE
-3.00%
$16.16
RIG
+0.24%
$4.02
NIO
-1.21%
$6.08
GOOGL
+3.20%
$285.26
AAL
-3.29%
$12.34
MARA
-6.71%
$11.18
GPUS
-12.37%
$0.24
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
SNAP
-5.89%
$8.06
ADD
-25.47%
$0.05
HPE
-7.74%
$21.06
PLTR
-3.12%
$168.56
MSPR
+13.64%
$0.51
ASBP
-10.91%
$0.09
RGTI
-3.56%
$24.57
SRM
+53.27%
$10.30
WULF
+0.29%
$11.02
PLTD
+2.57%
$7.01
XPEV
-10.23%
$22.44
GRAB
-1.81%
$5.31
BTG
-2.57%
$3.99
RXRX
-4.38%
$4.14
CAN
-5.35%
$0.84
HOOD
-7.13%
$113.76
GOOG
+3.15%
$285.73
AMD
-3.26%
$238.76
OWL
-5.77%
$13.77
HIMS
-3.78%
$35.58
WLGS
-5.57%
$0.04
MSFT
+1.36%
$510.18
MTSR
-0.35%
$70.50
AMC
-5.92%
$2.14
NOK
-0.31%
$6.70
IONZ
-1.30%
$5.13
IREN
-0.28%
$46.23
SMCI
-6.42%
$34.08
BTBT
-3.32%
$2.32
BBD
-1.76%
$3.61
WBD
-1.77%
$22.62
ABEV
-0.39%
$2.54
MU
-2.57%
$240.47
SOUN
-6.32%
$11.40
QBTS
-5.16%
$22.39
TWOH
0.00%
$0.00
BTE
-4.69%
$3.01
AFMD
-34.94%
$0.18
CLSK
-3.42%
$10.58
T
-0.29%
$25.51
QS
-3.42%
$12.97
CORZ
-1.51%
$14.93
BAC
-2.03%
$51.53
PLTZ
+5.52%
$7.26
IVVD
+20.14%
$2.82
APLD
-3.08%
$22.92
EOSE
-6.03%
$12.96
CRWV
-4.87%
$73.58
BULL
-4.21%
$8.63
CRCL
-6.78%
$76.33
CRCA
-13.69%
$4.16
CGC
-2.24%
$1.04
SMR
-7.19%
$20.83

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.